EUVIMEDEUVIMED entdecken
Historischer BeitragÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

A Brief History of Inherited Metabolic Diseases: A Personal 60 Years Clinical Flashback

Jean-Marie Saudubray, Manuel Schiff iD

Journal of Inherited Metabolic Disease · 2025

DOI: 10.1002/jimd.70063 ↗

Kurz gefasst

Historischer Beitrag in der Zeitschrift Journal of Inherited Metabolic Disease, 2025. Verfasst von Jean-Marie Saudubray und 1 weiteren Autor:innen. Beteiligte Einrichtung: Paris, France. Hauptthemen laut MEDLINE: Metabolism, Inborn Errors, Metabolic Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The concept of IMDs has evolved over a century from rare deficits in amino acid catabolism diagnosed by the accumulation of biochemical markers such as phenylketonuria (PKU) to diseases affecting organelle metabolism, synthesis of complex molecules, and cellular trafficking. Small‐molecule accumulation disorders form the major group of treatable IMDs. Do not miss these metabolic emergencies! IMDs currently number over 1800 and include all medical specialties. The specificity of true “molecular internists,” metabolic specialists, lies in the in‐depth knowledge of metabolic pathways and the understanding of the pathophysiology of the deficits underlying the treatments (“precision medicine”). Neurology is massively impacted, but cerebral metabolism remains largely misunderstood. Genetic analyses are becoming increasingly important for diagnosis but must be complemented by biochemical investigations, which sometimes have greater diagnostic specificity and provide functional information at the phenotype level. Biochemical analyses remain essential for monitoring treatment or even for diagnosis. Finally, contrary to early expectations, newborn screening such as that for phenylketonuria, leading to preventive therapy, could be extended to a significant though limited number of IMDs. Currently, there are numerous initiatives that include genetic screening combined with biochemical testing or that extend screening to lysosomal diseases potentially treatable by enzyme or gene therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolism, Inborn ErrorsMetabolic DiseasesHumansHistory, 20th CenturyHistory, 21st CenturyNeonatal ScreeningPhenylketonurias

Stichwörter der Autor:innen

Inborn metabolic diseasesInherited metabolic diseasesMetabolic disordersPrecision medicineinborn errors of metabolism

Autor:innen und Institutionen

  • Paris, France.
  • Reference Center for Inborn Errors of Metabolism, Department of Pediatrics, Necker Hospital, APHP, Université Paris-Cité, G2M Network, MetabERN, Paris, France.
  • Inserm UMR _S1163, Institut Imagine, Paris, France.

ORCID-Profile: Manuel Schiff

Zitieren

APA

Saudubray, J. M., & Schiff, M. (2025). A Brief History of Inherited Metabolic Diseases: A Personal 60 Years Clinical Flashback. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.70063

Vancouver

Saudubray JM, Schiff M. A Brief History of Inherited Metabolic Diseases: A Personal 60 Years Clinical Flashback. Journal of Inherited Metabolic Disease. 2025. doi:10.1002/jimd.70063

BibTeX
@article{Saudubray2025,
  author = {Saudubray, Jean-Marie and Schiff, Manuel},
  title = {A Brief History of Inherited Metabolic Diseases: A Personal 60 Years Clinical Flashback},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2025},
  doi = {10.1002/jimd.70063}
}
Kostenlos starten →